Bemarituzumab (Anti-FGFR2 / CD332)
Product Specifications
CAS Number
1952272-74-0
Target
FGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Bemarituzumab (Anti-FGFR2 / CD332) is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor) . Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research. MW: 145.24 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2398108 1.0 µg DNA
TMEM127 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details MBS1375039 Inquire
Recombinant Human Zinc finger protein 532 (ZNF532) , partial
Sign In for Pricing
View Details ![LGALS3BP Mouse Monoclonal Antibody [Clone 3G8]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
